Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Sacroiliitis Treatment Market Research Report: Information By Type (Medications, Joint Injections, Joint Fusion, Radiofrequency Denervation, and Electrical Stimulation) and By End Users (Hospitals, Clinics, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/HC/5127-HCR | 85 Pages | Author: Kinjoll Dey| April 2024

Market Segmentation


Sacroiliitis Treatment Type Outlook (USD Billion, 2018-2032)




  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation




Sacroiliitis Treatment End-User Outlook (USD Billion, 2018-2032)




  • Hospitals




  • Clinics






  • Others




Sacroiliitis Treatment Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)






  • Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics





      • Others










    • US Outlook (USD Billion, 2018-2032)







  • US Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • US Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • CANADA Outlook (USD Billion, 2018-2032)







  • CANADA Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • CANADA Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others






  • Europe Outlook (USD Billion, 2018-2032)






  • Europe Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Europe Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • Germany Outlook (USD Billion, 2018-2032)







  • Germany Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Germany Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • France Outlook (USD Billion, 2018-2032)







  • France Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • France Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • UK Outlook (USD Billion, 2018-2032)







  • UK Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • UK Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • ITALY Outlook (USD Billion, 2018-2032)







  • ITALY Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • ITALY Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • SPAIN Outlook (USD Billion, 2018-2032)







  • SPAIN Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • SPAIN Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • Rest Of Europe Outlook (USD Billion, 2018-2032)







  • Rest Of Europe Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Rest Of Europe Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics








      • Others






  • Asia-Pacific Outlook (USD Billion, 2018-2032)






  • Asia-Pacific Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Asia-Pacific Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • China Outlook (USD Billion, 2018-2032)







  • China Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • China Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • Japan Outlook (USD Billion, 2018-2032)







  • Japan Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Japan Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics








      • Others





    • India Outlook (USD Billion, 2018-2032)







  • India Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • India Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • Australia Outlook (USD Billion, 2018-2032)







  • Australia Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Australia Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)







  • Rest of Asia-Pacific Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Rest of Asia-Pacific Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others






  • Rest of the World Outlook (USD Billion, 2018-2032)






  • Rest of the World Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Rest of the World Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • Middle East Outlook (USD Billion, 2018-2032)







  • Middle East Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Middle East Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • Africa Outlook (USD Billion, 2018-2032)







  • Africa Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Africa Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others







    • Latin America Outlook (USD Billion, 2018-2032)







  • Latin America Sacroiliitis Treatment by Type






  • Medications




  • Joint Injections




  • Joint Fusion




  • Radiofrequency Denervation




  • Electrical Stimulation






  • Latin America Sacroiliitis Treatment by End-User






  • Hospitals




  • Clinics




  • Others



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Sacroiliitis Treatment Market, by Type

6.1 Introduction

6.2 Medication

6.2.1 Pain relievers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1 Muscle relaxants

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1 TNF inhibitors

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Joint injections

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Radiofrequency denervation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Electrical stimulation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6 Joint fusion

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Sacroiliitis Treatment Market, by End-Users

7.1 Introduction

7.2 Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Ambulatory care

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Homecare

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Diagnostic centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Sacroiliitis Treatment Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Pfizer

10.1.1 Company Overview

10.1.2 Type Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Allergan

10.2.1 Company Overview

10.2.2 Type Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Ipsen Group

10.3.1 Company Overview

10.3.2 Type Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Teva Pharmaceuticals

10.4.1 Company Overview

10.4.2 Technology/Business Segment Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Novartis

10.5.1 Company Overview

10.5.2 Type Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Johnson & Johnson

10.6.1 Company Overview

10.6.2 Type Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 STEROID S.p.A.

10.7.1 Overview

10.7.2 Type Overview

10.7.3 Financial Overview

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 Sanofi

10.8.1 Overview

10.8.2 Type/ Technology Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Bioventus

10.9.1 Overview

10.9.2 Type Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 Salix Pharmaceuticals

10.10.1 Overview

10.10.2 Type Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.11 Zimmer Holdings, Inc.

10. 11.1 Overview

10. 11.2 Type Overview

10. 11.3 Financials

10. 11.4 Key Developments

10.111.5 SWOT Analysis

10.12 Smith & Nephew Plc

10.12.1 Overview

10.12.2 Type Overview

10.12.3 Financials

10.12.4 Key Developments

10.12.5 SWOT Analysis

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s Viewpoint

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the Sacroiliitis Treatment Industry

Chapter 12. Appendix

LIST OF TABLES

Table 1 Global Sacroiliitis Treatment Market Synopsis, 2020-2027

Table 2 Global Sacroiliitis Treatment Market Estimates and Forecast, 2020-2027(USD Million)

Table 3 Global Sacroiliitis Treatment Market, by Region, 2020-2027(USD Million)

Table 4 Global Sacroiliitis Treatment Market, by Type, 2020-2027(USD Million)

Table 7 Global Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 8 North America: Sacroiliitis Treatment Market, by Type, 2020-2027(USD

Million)

Table 9 North America: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 10 US: Sacroiliitis Treatment Market, by Type, 2020-2027(USD Million)

Table 15 US: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 16 Canada: Sacroiliitis Treatment Market, by Type, 2020-2027(USD Million)

Table 17 Canada Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 20 South America: Sacroiliitis Treatment Market, by Type, 2020-2027(USD

Million)

Table 23 South America: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 24 Europe: Sacroiliitis Treatment Market, by Type, 2020-2027(USD Million)

Table 27 Europe: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 28 Western Europe: Sacroiliitis Treatment Market, by Type, 2020-2027(USD

Million)

Table 31 Western Europe: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 32 Eastern Europe: Sacroiliitis Treatment Market, by Type, 2020-2027(USD

Million)

Table 35 Eastern Europe: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 36 Asia-Pacific: Sacroiliitis Treatment Market, by Type, 2020-2027(USD

Million)

Table 37 Asia-Pacific: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Table 40 Middle East & Africa: Sacroiliitis Treatment Market, by Type, 2020-2027

(USD Million)

Table 43 Middle East & Africa: Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Sacroiliitis Treatment Market

Figure 3 Segmentation Market Dynamics for Global Sacroiliitis Treatment Market

Figure 4 Global Sacroiliitis Treatment Market Share, by Type, 2020

Figure 5 Global Sacroiliitis Treatment Market, by End-users, 2020-2027(USD Million)

Figure 6 Global Sacroiliitis Treatment Market Share, by Region, 2020

Figure 7 North America: Sacroiliitis Treatment Market Share, by Country, 2020

Figure 8 Europe: Sacroiliitis Treatment Market Share, by Country, 2020

Figure 9 Asia-Pacific: Sacroiliitis Treatment Market Share, by Country, 2020

Figure 10 Middle East & Africa: Sacroiliitis Treatment Market Share, by Country, 2020

Figure 11 Global Sacroiliitis Treatment Market: Company Share Analysis, 2020 (%)

Figure 12 Pfizer: Key Financials

Figure 13 Pfizer: Segmental Revenue

Figure 14 Pfizer: Geographical Revenue

Figure 15 Allergan: Key Financials

Figure 16 Allergan: Segmental Revenue

Figure 17 Allergan: Geographical Revenue

Figure 18 Ipsen Group: Key Financials

Figure 19 Ipsen Group: Segmental Revenue

Figure 20 Ipsen Group: Geographical Revenue

Figure 21 Teva Pharmaceuticals: Key Financials

Figure 22 Teva Pharmaceuticals: Segmental Revenue

Figure 23 Teva Pharmaceuticals: Geographical Revenue

Figure 24 Novartis: Key Financials

Figure 25 Novartis: Segmental Revenue

Figure 26 Novartis: Geographical Revenue

Figure 27 Johnson & Johnson: Key Financials

Figure 28 Johnson & Johnson: Segmental Revenue

Figure 29 Johnson & Johnson: Geographical Revenue

Figure 30 STEROID S.p.A.: Key Financials

Figure 31 STEROID S.p.A.: Segmental Revenue

Figure 32 STEROID S.p.A.: Geographical Revenue

Figure 33 Sanofi: Key Financials

Figure 34 Sanofi: Segmental Revenue

Figure 35 Sanofi: Geographical Revenue

Figure 36 Bioventus: Key Financials

Figure 37 Bioventus: Segmental Revenue

Figure 38 Bioventus: Geographical Revenue

Figure 39 Salix Pharmaceuticals: Key Financials

Figure 40 Salix Pharmaceuticals: Segmental Revenue

Figure 41 Salix Pharmaceuticals: Geographical Revenue

Figure 42 Zimmer Holdings Inc.: Key Financials

Figure 43 Zimmer Holdings Inc.: Segmental Revenue

Figure 44 Zimmer Holdings Inc.: Geographical Revenue

Figure 45 Smith & Nephew Plc.: Key Financials

Figure 46 Smith & Nephew Plc.: Segmental Revenue

Figure 47 Smith & Nephew Plc.: Geographical Revenue

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.